“We have created a stable active ingredient”
-
- "I’m thrilled that our basic research is showing what it is capable of," says Andreas Plückthun. (Image: Ursula Meisser)
Molecular Partners, a spin-off from the University of Zurich, has developed a drug against Covid-19 and is applying for approval, together with Novartis, in Switzerland and the US. Phase 2 clinical trials have already demonstrated efficacy in Covid patients.
The new drug Ensovibep is particularly effective for acute, outpatient Covid-19 cases, reducing the risk of hospitalization or emergency room visits and death by 80 percent, according to the manufacturers. In addition, recovery was faster and better compared to the placebo group. Although phase 3 clinical trials are still pending, the researchers believe the chances of success are high. Novartis has already announced its intention to acquire the license for Ensovibep from Molecular Partners for 150 million Swiss francs. Novartis would then lead the late-stage development and commercialization.
More news
- Protein shapes indicate Parkinson’s disease
- The seeds have germinated
- Watching the metabolism at work
- A Fountain of Youth for Blood Vessels
- In the Jungle of Neurons
- Fighting tumours with magnetic bacteria
- How genetics influences our body weight beyond the genes
- Immunotherapy Reduces Lung and Liver Fibrosis in Mice
- Preparing for future coronavirus variants using artificial intelligence
- Determining why the Arctic is turning ever greener
- Seeds for All
- First map of immune system connections reveals new therapeutic opportunities
- Global Spread of Powdery Mildew through Migration and Trade
- Resistance to mosaic disease in cassava explained
- Individual Cells Are Smarter Than Thought
- Social Development of Infants Unaffected by Covid-19 Pandemic
- Wonderful World of Wheat
- Severe flu risk as immune cells swap with age
- Dangerous Bites
- Tapping the ocean as a source of natural products
- Breast cancer spreads at night
- In the Beginning Was the Popcorn
- Diverse Forests Outyield Monocultures
- World Premiere: Successful Transplant of Human Liver Treated in Machine
- Dolphins Self-Medicate Skin Ailments at Coral “Clinics”
- Bacteria with recording function capture gut health status
- Environmental DNA reveals secret reef inhabitants
- Astrocyte Networks in the Mouse Brain Control Spatial Learning and Memory
- Like bacteria firing spearguns
- New drug candidates identified in bacteria
- Immunological Memory Provides Long-Term Protection against Coronavirus
- “Animal experiments will remain indispensable in the foreseeable future”
- Agents between good and evil
- AI offers a faster way to predict antibiotic resistance
- Evidence-Based Contribution of Mechano-Biological Descriptors of Resistance Exercise
- Mechanism for DNA Invasion of Adenoviral Covid-19 Vaccines Discovered
- Saving infants' lives with iron
- Rapid PCR tests at the touch of a button
- When Resistant Germs Travel
- When Stress Makes You Sick
- Healthy People, Healthy Animals
- We are less sceptical of genetic engineering than assumed
- Humans and Chimps
- Computer algorithms are currently revolutionising biology
- Toxicity testing on the placenta and embryo
- Courting Females
- Eating Our Way Through the Pandemic
- Optimising nature
- Luring bacteria into a trap
- A deep dive into the brain
- How tendons become stiffer and stronger
- The African Wild Dog: An Ambassador for the World’s Largest Terrestrial Conservation Area
- The Achilles heel of the Coronavirus
- A simple exterior – but complex interior
- Brain Tumors under Attack
- Planting Underpants
- How bacteria sleep through antibiotic attacks
- Synchronization of Brain Hemispheres Changes What We Hear
- Unusual mutation causes defective sperm in boars
- Detailed tumour profiling
- How a large protein complex assembles in a cell
- What immune cells reveal about sleep disorders
- Depression therapy: Adrift on the Ocean
- Which factors trigger leaf die-off in autumn?
- Medical microrobots score the Breakthrough of the Year
- Understanding mutations at different levels of the cell